Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2013-02-21
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability and efficacy of AQW051 in treating moderate
to severe L-dopa induced dyskinesias (movement disorders) in patients with Parkinson's
disease.